DBF4 and breast carcinoma: To date, only one study investigated the overexpression of Cdc7-Dbf4 in many in vitro tumor lines, linking this overexpression with p53 mutations [32], albeit specific overexpression of DBF4 in primary human breast cancer was not confirmed.